Jump to content

MDV3100 clinical trial Professor Frank Gardiner in Brisbane


JimmyToowong

Recommended Posts

John Stead has sent through this trial of MDV3100.

It is for prostate cancer progressing despite hormone therapy, with no chemotherapy so far.

post-3-0-91363700-1315862546_thumb.png

This trial is called the PREVAIL trial.

It is a standard placebo-controlled, randomized, double blind study.

That means that half the men will get a MDV3100 pill and the other half of the men will get a fake pill that looks and tastes the same.

At the end of the study, the groups will be compared to see how they did in:

  • Overall Survival
  • Progression-free Survival
  • Time to first skeletal-related event
  • Time to initiation of cytotoxic chemotherapy.

The ClinicalTrials.gov Identifier: NCT01212991

That means, to find the details, click on

ClinicalTrials.gov

and type:

NCT01212991

in the search box.

Australia, New South Wales

Recruiting

Concord, New South Wales, Australia

Recruiting

Kogarah, New South Wales, Australia

Recruiting

Lismore, New South Wales, Australia

Recruiting

Port Macquarie, New South Wales, Australia

Recruiting

Randwick, New South Wales, Australia

Recruiting

Wahroonga, New South Wales, Australia

Recruiting

Watarah, New South Wales, Australia

Recruiting

Westmead, New South Wales, Australia

Australia, Queensland

Recruiting

Herston, Queensland, Australia

Recruiting

South Brisbane, Queensland, Australia

Australia, South Australia

Recruiting

Kurralta Park, South Australia, Australia

Australia, Victoria

Recruiting

Bendigo, Victoria, Australia

Recruiting

Box Hill, Victoria, Australia

Recruiting

East Melbourne, Victoria, Australia

Recruiting

Footscray, Victoria, Australia

Recruiting

Geelong, Victoria, Australia

Recruiting

Heidelberg, Victoria, Australia

Recruiting

Parkville, Victoria, Australia

Australia

Recruiting

New South Wales, Australia

MDV3100 Brisbane Clinical Trial.pdf

Link to comment
Share on other sites

  • 3 weeks later...
Guest PaulHoskins

MDV3100 (PREVAIL) Trial

On receiving the information regarding the trial I sent my details down to Robyn Medcraft, the RN Urology Research Coordinator at the UoQ.

I received and reviewed the Patient Information and Consent Forms. The trial appears to be very detailed, with monthly checks, Quarterly CT Scans, Bone Scans & MRI's.

Last week Robyn contacted me to advise that I was not able to participate in the trial as I have had ERBT to my Sacrum. People who have had ERBT to their Prostate are eligible but not those who have had ERBT on any other areas.

Link to comment
Share on other sites

Guest PaulHoskins

After receiving the e-mail in regard to the MDV3100 Trial, to be performed at the University of Qld by Prof. Frank Gardiner, I sent my Prostate Cancer details down for their review and suitability for inclusion.

Having read the initial inclusion requirements I appeared to fit the bill;

  • Cheotherapy-Naive
  • Progressive Metastatic Pca
  • Failed initial ADT

I received the 'Participant Information and Consent Form' on 22 September and had just finished reading the procedures for a second time when I received an e-mail from Robyn Medcraft RN Urology Research Coordinator.

The following is the body of the e-mail;'

I have had a meeting with the clinical trial monitor today and discussed your eligibility, unfortunately you have received ERBT on bony mets in your S1 Sacrum, as per the protocol of this trial you are only eligible if you have only received ERBT to your Prostate.

Paul I'm really sorry that you don't fit the criteria for this trial but I can ask professor Gardiner if he knows of any other trials about.'

So, back to the drawing board.

Paul Hoskins

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...